Evidence map›Paper›PMID 24291354›Full record

ArticleJournal of proteomics2014

A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic islets.

Sara Sileno, Valentina D'Oria, Riccardo Stucchi, Massimo Alessio, Stefania Petrini, Valentina Bonetto, Pierre Maechler, Federico Bertuzzi, Valeria Grasso, Katia Paolella and 2 more

Abstract read
In one paragraph

Article in Journal of proteomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sara SilenoResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Valentina D'OriaConfocal Microscopy Core Facility, Research Laboratory, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy.
Riccardo StucchiDulbecco Telethon Institute at IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Massimo AlessioProteome Biochemistry Unit, San Raffaele Scientific Institute, Milan, Italy.
Stefania PetriniConfocal Microscopy Core Facility, Research Laboratory, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy.
Valentina BonettoDulbecco Telethon Institute at IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Pierre MaechlerDepartment of Cell Physiology and Metabolism, Geneva University Medical Centre, Geneva 4, Switzerland.
Federico BertuzziEndocrinology Unit, Niguarda Hospital, Milan, Italy.
Valeria GrassoResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Katia PaolellaDulbecco Telethon Institute at IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Fabrizio BarbettiResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; Department of Experimental Medicine and Surgery, University of Tor Vergata, Rome, Italy.
Ornella MassaResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address: o.massa@virgilio.it.
Bambino Gesù Children's Hospital · ITDulbecco Telethon Institute · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITSan Raffaele University of Rome · ITUniversity of Rome Tor Vergata · IT

Funding

Telethon GGP09147
6 · The paper itself

Abstract

Transglutaminase 2 (TG2) is a multifunctional protein with Ca(2+)-dependent transamidating and G protein activity. Previously we reported that the role of TG2 in insulin secretion may involve cytoplasmic actin remodeling and a regulative action on other proteins during granule movement. The aim of this study was to gain a better insight into the role of TG2 transamidating activity in mitochondria and in the nucleus of INS-1E rat insulinoma cell line (INS-1E) during insulin secretion. To this end we labeled INS-1E with an artificial donor (biotinylated peptide), in basal condition and after stimulus with glucose for 2, 5, and 8min. Biotinylated proteins of the nuclear/mitochondrial-enriched fraction were analyzed using two-dimensional electrophoresis and mass spectrometry. Many mitochondrial proteins involved in Ca(2+) homeostasis (e.g. voltage-dependent anion-selective channel protein, prohibitin and different ATP synthase subunits) and many nuclear proteins involved in gene regulation (e.g. histone H3, barrier to autointegration factor and various heterogeneous nuclear ribonucleoprotein) were identified among a number of transamidating substrates of TG2 in INS-1E. The combined results provide evidence that a temporal link exists between glucose-stimulation, first phase insulin secretion and the action of TG on histone H3 both in INS-1E and human pancreatic islets. BIOLOGICAL SIGNIFICANCE: Research into the role of transglutaminase 2 during insulin secretion in INS-1E rat insulinoma cellular model is depicting a complex role for this enzyme. Transglutaminase 2 acts in the different INS-1E compartments in the same way: catalyzing a post-translational modification event of its substrates. In this work we identify some mitochondrial and nuclear substrates of INS-1E during first phase insulin secretion. The finding that TG2 interacts with nuclear proteins that include BAF and histone H3 immediately after (2-5min) glucose stimulus of INS-1E suggests that TG2 may be involved not only in insulin secretion, as suggested by our previous studies in cytoplasmic INS-1E fraction, but also in the regulation of glucose-induced gene transcription.

Indexed as

AnimalsCalciumCell Line, TumorCell NucleusGlucoseGTP-Binding ProteinsHumansInsulinInsulin-Secreting CellsInsulin SecretionProtein Glutamine gamma Glutamyltransferase 2RatsSweetening AgentsTranscription, GeneticTransglutaminasesCalciumGlucoseGTP-Binding ProteinsInsulinProtein Glutamine gamma Glutamyltransferase 2Sweetening AgentsTgm2 protein, ratTransglutaminasesCalcium concentrationfirst phase insulin secretionFPISHuman isletINS-1EInsulin secretionTG2transglutaminase 2.Transglutaminase 2β-Cell

Identifiers

PMID24291354
PMCPMC3919173
OpenAlexW1975069292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.